You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Safety of Len/Dex

Showing 1 - 25 of 247
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)

Recruiting
  • Multiple Myeloma in Relapse
  • +5 more
  • London, Ontario, Canada
    London Health Sciences Centre
Oct 3, 2022

MULTIPLE MYELOMA (MM) Trial in Rionero in Vulture (Carfilzomib, Cyclophosphamide, Lenalidomide)

Active, not recruiting
  • MULTIPLE MYELOMA (MM)
  • Rionero in Vulture, Italy
    IRCCS--CROB --CROB di Rionero in di Rionero in Vulture
Apr 28, 2021

Multiple Myeloma in Relapse Trial in Paris (Daratumumab/Lenalidomide/Dexamethasone for 24 months,

Recruiting
  • Multiple Myeloma in Relapse
  • Daratumumab/Lenalidomide/Dexamethasone for 24 months
  • Daratumumab/Lenalidomide/Dexamethasone until progression
  • Paris, France
    Saint Antoine Hospital - Hematology Department
Jun 10, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Birmingham, Alabama
  • +25 more
Dec 9, 2022

Multiple Myeloma Trial in Portugal (Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Almada, Portugal
  • +11 more
Jun 27, 2022

Kyprolis® in Combination With Revlimid® and Dexamethasone or

Recruiting
  • Multiple Myeloma in Relapse
  • Frankfurt, Germany
    Centrum für Hämatologie und Onkologie Bethanien
Jun 2, 2022

Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

Recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center
Jun 10, 2022

Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Tablet, Lenacapavir Injection, Emtricitabine/Tenofovir Disoproxil

Not yet recruiting
  • Pre-Exposure Prophylaxis of HIV Infection
  • Lenacapavir Tablet
  • +2 more
  • (no location specified)
Oct 20, 2023

Smoldering Myeloma, Smoldering Multiple Myeloma Trial in United States (Elotuzumab, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Myeloma
  • Smoldering Multiple Myeloma
  • Denver, Colorado
  • +8 more
Nov 1, 2021

Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Injection, Lenacapavir Tablet, Emtricitabine/tenofovir disoproxil

Not yet recruiting
  • Pre-Exposure Prophylaxis of HIV Infection
  • Lenacapavir Injection
  • +2 more
  • (no location specified)
Oct 20, 2023

Multiple Myeloma Trial in United States (elotuzumab, Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Denver, Colorado
  • +5 more
Oct 25, 2021

Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

Not yet recruiting
  • Multiple Myeloma
  • idecabtagene vicleucel
  • +3 more
  • Gilbert, Arizona
  • +107 more
Sep 26, 2023

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Carfilzomib)

Terminated
  • Multiple Myeloma
  • Encinitas, California
  • +5 more
Mar 15, 2022

Follicular Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Tocilizumab, Lenalidomide)

Recruiting
  • Follicular Lymphoma
  • Mosunetuzumab (IV)
  • +3 more
  • Duarte, California
  • +21 more
Jan 10, 2023

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Lenvatinib Plus I-125 Seed Brachytherapy, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Nov 2, 2022

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Lenvatinib plus sintilimab, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Nov 2, 2022

Nasal Packing, Dexmedetomidine, Turbinate Trial in Kafr Ash Shaykh (Nasal packing Dexmedetomidine, Intravenous Dexmedetomidine)

Not yet recruiting
  • Nasal Packing
  • +2 more
  • Nasal packing Dexmedetomidine
  • Intravenous Dexmedetomidine
  • Kafr Ash Shaykh, Karelsheikh, Egypt
    Karelsheikh University Hospital
Jun 10, 2023

Multiple Myeloma Trial (Pembrolizumab, Lenalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Pembrolizumab
  • +3 more
  • (no location specified)
Mar 12, 2021

Cochlear Implant Trial in Germany (Cochlear Implant)

Not yet recruiting
  • Cochlear Implant
  • Cochlear Implant
  • Bochum, Germany
  • +6 more
Nov 16, 2023

Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +126 more
Jan 10, 2023

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Sin-Bev-TACE, Len-TACE)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Aug 2, 2023

Intravitreal Dexamethasone Implant for Refractory Diabetic

Completed
  • Diabetic Macular Edema
  • Intravitreal Dexamethasone Implant for refractory Diabetic macular edema:
  • Cairo, Egypt
    Kasr alainy faculty of medicine
May 5, 2023

Adult Diabetic Macular Edema and Suboptimal Response to

Not yet recruiting
  • Diabetic Macular Edema
    • (no location specified)
    Jul 31, 2023

    Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

    Recruiting
    • Lymphoma
    • Beijing, China
    • +2 more
    Oct 12, 2023